[{"title": "Myocardial Disarray and Fibrosis across Hypertrophic Cardiomyopathy Stages Associate with ECG Markers of Arrhythmic Risk", "link": "https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeae260/7824545", "details": "Z Ashkir, AHA Samat, R Ariga, L Finnigan, S Jermy\u2026 - European Heart Journal \u2026, 2024", "abstract": "Background Myocardial disarray, an early feature of hypertrophic cardiomyopathy (HCM) and a substrate for ventricular arrhythmia, is poorly characterised in prehypertrophic sarcomeric variant carriers (SARC+ LVH-). Objectives Using \u2026"}, {"title": "Incremental Prognostic Value of a Coronary Heart Disease Polygenic Risk Score in Type 2 Diabetes", "link": "https://diabetesjournals.org/care/article/doi/10.2337/dc24-1489/157360", "details": "IR Mordi, I Li, G George, RJ McCrimmon, CN Palmer\u2026 - Diabetes Care, 2024", "abstract": "OBJECTIVE The recent availability of cardiovascular risk-reducing type 2 diabetes (T2D) therapies makes it imperative to optimally identify individuals who could derive benefit. Current clinical risk prediction may misclassify individuals as low risk and \u2026"}, {"title": "A Novel Deep Ensemble Method for Selective Classification of Electrocardiograms", "link": "https://ieeexplore.ieee.org/abstract/document/10707357/", "details": "A Argha, H Alinejad-Rokny, M Baumgartner, G Schreier\u2026 - IEEE Transactions on \u2026, 2024", "abstract": "Objective: Telehealth paradigms are essential for remotely managing patients with chronic conditions. To assist clinicians in handling the large volumes of data collected through these systems, clinical decision support systems (CDSSs) have \u2026"}, {"title": "Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathy", "link": "https://www.medrxiv.org/content/medrxiv/early/2024/10/16/2024.10.15.24315469.full.pdf", "details": "I Yan, Z Moehring, D Reichart, J Muench, R Woitschach\u2026 - medRxiv, 2024", "abstract": "Aims: Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy mainly caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin binding protein C3 and myosin heavy chain 7, respectively. These variants can cause \u2026"}]
